Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
Explore this paper's citation graph
Summary
The proposed tumor-node-metastases categories and stage groupings for cutaneous melanoma patients were validated and incorporated into the AJCC melanoma staging as described in the companion publication.
- Type
- article
- Published
- 2001-08-15
- Cited by
- 2,383
- References
- 75
- OpenAlex
- https://openalex.org/W1951046932
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:35350763
Keywords
Medicine, Melanoma, Occult, Cancer, Proportional hazards model
References
- Prognostic factors in thin cutaneous malignant melanoma
- A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
- Prognostic factors in 1,521 melanoma patients with distant metastases.
- Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
- Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.
- Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
- S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma.
- High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.
- A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
- Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.
- Independent prognostic importance of vascular invasion in nodular melanomas
- Lymph Node Tumor Volumes in Patients Undergoing Sentinel Lymph Node Biopsy for Cutaneous Melanoma
- INTERNATIONAL PATHOLOGISTS CONGRUENCE SURVEY ON QUANTITATION OF MALIGNANT MELANOMA
- Stage II malignant melanoma: Presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients
- Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation.
- Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985
- PROGNOSTIC HISTOPATHOLOGICAL FACTORS IN MALIGNANT MELANOMA
- Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)
- Stage I melanoma of the skin: Evaluation of prognosis according to histologic characteristics
Cited by
- [Pigmented lesions of the genital mucosa].
- In-transit melanoma: an individualized approach.
- Prognostic factors in primary cutaneous melanoma.
- Surgical treatment of malignant melanoma.
- Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma
- Partial Regression of Primary Cutaneous Melanoma: Is There an Association with Sub-Clinical Sentinel Lymph Node Metastasis?
- Immunization of Patients with Malignant Melanoma with Autologous CD34+ Cell-Derived Dendritic Cells Transduced Ex Vivo with a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I Trial
- Management of in‐transit metastases from cutaneous malignant melanoma
- Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
- Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis.
- Malignant melanoma in Taiwan: a prognostic study of 181 cases
- A quoi servent les modifications de la classification du mélanome
- [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
- Management of early-stage cutaneous melanoma.
- Survival analysis after resection of metastatic disease followed by peptide vaccines in patients with Stage IV melanoma
- Chemokines, chemokine receptors, and cancer metastasis
- Cutaneous malignant melanoma.
- Renal metastasis of malignant melanoma with unknown primary.
- Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma
- The role of VEGF-C staining in predicting regional metastasis in melanoma
Related papers
- Prognosis of esophageal squamous cell carcinoma patients with preoperative radiotherapy: Comparison of different cancer staging systems
- A comparison of staging systems for nasopharyngeal carcinoma
- Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.
- A comparison of staging systems for nasopharyngeal carcinoma
- Proposed Modification of Nodal Staging as an Alternative to the Seventh Edition of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Improves the Prognostic Prediction in the Resected Esophageal Squamous-Cell Carcinoma
- Nasopharyngeal carcinoma in a non-endemic country-Validation of the new NPC staging system.
- Evaluation of the American Joint Committee on Cancer Staging System for Cutaneous Squamous Cell Carcinoma and Proposal of a New Staging System